BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33243007)

  • 1. Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
    Zhong PC; Shu R; Wu HW; Liu ZW; Shen XL; Hu YJ
    Exp Biol Med (Maywood); 2021 Mar; 246(5):560-571. PubMed ID: 33243007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.
    Karasinska JM; Topham JT; Kalloger SE; Jang GH; Denroche RE; Culibrk L; Williamson LM; Wong HL; Lee MKC; O'Kane GM; Moore RA; Mungall AJ; Moore MJ; Warren C; Metcalfe A; Notta F; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
    Clin Cancer Res; 2020 Jan; 26(1):135-146. PubMed ID: 31481506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
    Zhang Y; Zhu B; Cai Y; Zhu S; Zhao H; Ying X; Jiang C; Zeng J
    BMC Cancer; 2022 Jan; 22(1):2. PubMed ID: 34980012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
    Zhu Z; Qin J; Dong C; Yang J; Yang M; Tian J; Zhong X
    Bioengineered; 2021 Dec; 12(1):4780-4793. PubMed ID: 34346836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant gene expression pattern in the glycolysis-cholesterol synthesis axis is linked with immune infiltration and prognosis in prostate cancer: A bioinformatics analysis.
    Yuan Y; Song J; Wu Q
    Medicine (Baltimore); 2022 Oct; 101(43):e31416. PubMed ID: 36316896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
    Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
    Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
    Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
    Jiang J; Zheng Q; Zhu W; Chen X; Lu H; Chen D; Zhang H; Shao M; Zhou L; Zheng S
    Aging (Albany NY); 2020 Jun; 12(11):10300-10316. PubMed ID: 32479426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes.
    Zhang J; Xiao X; Guo Q; Wei Z; Hua W
    Comput Math Methods Med; 2022; 2022():9448144. PubMed ID: 35242216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
    Chen YJ; Guo X; Liu ML; Yu YY; Cui YH; Shen XZ; Liu TS; Liang L
    Front Immunol; 2022; 13():979521. PubMed ID: 36569910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
    Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
    Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
    Wang G; Liu X; Wang D; Sun M; Yang Q
    Front Oncol; 2021; 11():636565. PubMed ID: 33842342
    [No Abstract]   [Full Text] [Related]  

  • 14. Essential amino acid metabolism-related molecular classification in triple-negative breast cancer.
    Zhao Y; Pu C; Jiao D; Zhu J; Guo X; Liu Z
    Epigenomics; 2021 Aug; 13(16):1247-1268. PubMed ID: 34448400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
    Bareche Y; Venet D; Ignatiadis M; Aftimos P; Piccart M; Rothe F; Sotiriou C
    Ann Oncol; 2018 Apr; 29(4):895-902. PubMed ID: 29365031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
    FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
    Narrandes S; Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Jan; 18(1):22. PubMed ID: 29301506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
    Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E
    Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis.
    Deng W; Zhu P; Xu H; Hou X; Chen W
    J Oncol; 2022; 2022():2014625. PubMed ID: 36213830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.